Etybenzatropine

Etybenzatropine
Clinical data
Routes of; administration	Oral, IM, IV
ATC code	N04AC30 (WHO) ;
Identifiers
	IUPAC name (3-endo)-3-(Diphenylmethoxy)-8-ethyl-8-azabicyclo[3.2.1]octane;
CAS Number	524-83-4 ;
PubChem CID	71637;
ChemSpider	16736129 ;
UNII	G1X2X9N95N;
KEGG	D04087 ;
CompTox Dashboard (EPA)	DTXSID50905096 ;
Chemical and physical data
Formula	C22H27NO
Molar mass	321.464 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c3ccccc3)c4ccccc4;
	InChI InChI=1S/C22H27NO/c1-2-23-19-13-14-20(23)16-21(15-19)24-22(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12,19-22H,2,13-16H2,1H3/t19-,20+,21+ ; Key:PHTMLLGDZBZXMW-AERCQKQUSA-N ;
	(verify)

Etybenzatropine (INN), also known as ethybenztropine (USAN, BAN) and tropethydrylin, is an anticholinergic/antihistamine marketed under the trade names Panolid, Ponalid, and Ponalide, which is used as an antiparkinsonian agent.^[1] Like its analogue benzatropine, it may act as a dopamine reuptake inhibitor.^{[citation needed]}

References

^ Pourcher E, Bonnet AM, Kefalos J, Dubois B, Agid Y (1989). "Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease". Movement Disorders. 4 (3): 195–201. doi:10.1002/mds.870040301. PMID 2779590.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.